Get the Stockscreener App
81.79
8.76%
-8.02
Grail Inc stock is traded at $81.79, with a volume of 1.25M.
It is down -8.76% in the last 24 hours and up +25.01% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$89.81
Open:
$85.87
24h Volume:
1.25M
Relative Volume:
1.28
Market Cap:
$2.94B
Revenue:
$117.67M
Net Income/Loss:
$-1.88B
P/E Ratio:
-1.3511
EPS:
-60.5369
Net Cash Flow:
$-621.36M
1W Performance:
-5.12%
1M Performance:
+25.01%
6M Performance:
+129.04%
1Y Performance:
+486.12%
1-Day Range:
$81.02
$86.70
1-Week Range:
$81.02
$95.25
52-Week Range:
$13.52
$103.00
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
81.68 | 3.24B | 117.67M | -1.88B | -621.36M | -60.54 |
|
TMO
Thermo Fisher Scientific Inc
|
565.08 | 212.23B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
214.34 | 151.20B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
722.57 | 57.84B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.77 | 41.02B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
211.76 | 36.42B | 15.90B | 1.28B | 2.21B | 7.2842 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
Grail Inc Stock (GRAL) Latest News
Is GRAIL Inc. (NL0) stock undervalued historicallyJuly 2025 Snapshot & Fast Moving Stock Watchlists - newser.com
GRAIL (GRAL): Assessing Valuation Following New SYMPLIFY Study Results and Rising Industry Recognition - simplywall.st
Why Is GRAL Stock Rising Today? - MSN
Identifying reversal signals in GRAIL LLCJuly 2025 Levels & Community Trade Idea Sharing Platform - newser.com
Manulife Becomes First Canadian Insurer to Offer the Galleri® Multi-Cancer Early Detection Test by GRAIL - The Globe and Mail
Will GRAIL Inc. (NL0) stock attract long term capital inflows2025 Year in Review & Low Risk High Reward Trade Ideas - newser.com
GRAIL (GRAL) Is Up 8.2% After Strong SYMPLIFY Data Underscores Galleri’s Early Cancer Detection Potential - Yahoo! Finance Singapore
Bay Colony Advisory Group Inc d b a Bay Colony Advisors Purchases Shares of 4,525 GRAIL, Inc. $GRAL - MarketBeat
Why The Story Around GRAIL Is Shifting After Recent Analyst and Clinical Developments - Yahoo Finance
Pier Capital LLC Buys New Stake in GRAIL, Inc. $GRAL - MarketBeat
Did Positive SYMPLIFY Results Just Redefine GRAIL's (GRAL) Path in Early Cancer Detection? - simplywall.st
Focus Partners Advisor Solutions LLC Takes Position in GRAIL, Inc. $GRAL - MarketBeat
Brighton Jones LLC Makes New $283,000 Investment in GRAIL, Inc. $GRAL - MarketBeat
GRAIL (NASDAQ:GRAL) Trading 8.2% HigherHere's Why - MarketBeat
Class action complaint alleging GRAIL insider fraud resubmitted after dismissal - The Cancer Letter
Will GRAIL Inc. (NL0) stock boost dividends further2025 Earnings Surprises & Real-Time Volume Trigger Notifications - newser.com
How a Texas congressman won support for a controversial cancer test - Houston Chronicle
What analysts say about GRAIL Inc NL0 stockStock Correlation Metrics & High Profit Stock Alerts - earlytimes.in
What technical patterns form on GRAIL Inc. (NL0) stock chartsJuly 2025 Selloffs & Expert-Curated Trade Recommendations - newser.com
GRAIL to Announce Third Quarter 2025 Financial Results - Lelezard
Published on: 2025-10-30 01:55:10 - newser.com
How Illumina/Grail Is Affecting EU Merger Control 1 Year On - Law360
Can GRAIL LLC stock rebound after recent weaknessJuly 2025 Highlights & Target Return Focused Picks - Fundação Cultural do Pará
GRAIL (GRAL) Price Target Increased by 51.85% to 62.73 - Nasdaq
Cathie Wood Just Dumped More Palantir Shares Despite 'Holy Grail' AI Deal — Here's What Ark Bought Instead - Benzinga
Groundbreaking blood test can detect more than 50 cancers, Bay Area biotech says - KTVU
Illumina, Grail seek to recoup litigation costs over EU merger fight - MLex
Can GRAIL Inc. (NL0) stock deliver double digit returnsJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
Does GRAIL LLC stock trade at a discount to peersQuarterly Risk Review & Daily Oversold Stock Bounce Ideas - Fundação Cultural do Pará
Alex Karp Says New Lumen Deal Can Make AI Data '200x Faster,' 'Incrementally Cheaper:' 'The Holy Grail For Businesses' - Yahoo Finance
Samsung Electronics, Samsung C&T to invest US$110 mln in U.S. biotech firm Grail - MSN
Will GRAIL Inc. (NL0) stock keep raising dividendsPrice Action & Free Low Drawdown Momentum Trade Ideas - Fundação Cultural do Pará
GRAIL: Buy Τhe Test That Could Redefine Cancer Screening (NASDAQ:GRAL) - Seeking Alpha
VIRGINIA RETIREMENT SYSTEMS ET Al Takes $226,000 Position in GRAIL, Inc. $GRAL - MarketBeat
Jim Cramer on GRAIL: “Don’t Call Yourself Early if You’re Buying This One” - MSN
Published on: 2025-10-26 21:05:02 - newser.com
GRAIL (GRAL): Evaluating Valuation After Key Study Results and Samsung Partnership Propel Global Growth Prospects - Sahm
Weiss Ratings Reaffirms "Sell (D-)" Rating for GRAIL (NASDAQ:GRAL) - MarketBeat
GRAIL (NASDAQ:GRAL) Trading 11.2% HigherTime to Buy? - MarketBeat
Grail’s Stock Surges After Samsung Collaboration in Asia - timothysykes.com
Carnegie Investment Counsel Takes Position in GRAIL, Inc. $GRAL - MarketBeat
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.45%
7.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):